2019 Registry-Randomised Trials Colloquium – ADELAIDE

ACTA Summer School: Registry-Randomised Trials Colloquium Hear from trialists who have successfully run trials utilising clinical quality registries as well as policy makers and funders. Delegates will have the opportunity…

2019 Adaptive clinical trial designs: Melbourne

ACTA Summer School: Adaptive clinical trial designs: theory and hands-on skills development – Melbourne Join us for a two-day intensive workshop where you will take away the knowledge and practical…

2019 Adaptive clinical trial designs: Brisbane

ACTA Summer School: Adaptive clinical trial designs: theory and hands-on skills development – Brisbane Join us for a two-day intensive workshop where you will take away the knowledge and practical…

2019 Adaptive clinical trial designs: Sydney

ACTA Summer School: Adaptive Clinical Trial Designs: theory and hands-on skill development – Sydney Join us for a two-day intensive workshop where you will take away the knowledge and practical…

Consumer Involvement Toolkit

…International Clinical Trials Conference on Saturday 5 October 2019. Created by ACTA in collaboration with CT:IQ and a working group of consumers, researchers and research organisations, the Consumer Involvement and…

ACTA activity work plan 2019 – 2020

This activity plan outlines key activities to be undertaken in 2019-2020. The plan has been developed in consultation with the ACTA Board, ACTA Reference Groups and Special Interest Groups and…

HeSANDA Stakeholder Consultation

…date. Consultations will begin in late May and June and we will continue to bring you updates on the project. Please contact ACTA Project Officer, Fiona Nemeh (fiona.nemeh@clinicaltrialsalliance.org.au) if you…

Push to Make Clinical Trials More Diverse

…to clinical trials. Read the full ABC Story If you are interested in contributing ACTA’s projects on trial diversity and consumer involvement, engagement and awareness, please contact us at info@clinicaltrialsalliance.org.au….

National One-Stop-Shop

…One-Stop-Shop and the National Clinical Trials Front Door. Targeted consultations with state and territory health departments and health and medical research organisations will be followed by broad consultation across the…

Research Prioritisation workshops

…to learn about Research Prioritisation in CTNs An opportunity to participate in a moderated discussion with the workshop presenters. Questions? If you have any questions about the workshops, please contact: acta@clinicaltrialsalliance.org.au…

MedTech21 Virtual Conference

The MedTech21 Virtual Conference brings together leaders and influencers across the industry, government and academia to discuss the key issues affecting MedTech. This year has seen MedTech and the broader…

Inaugural Emerging Leader Investigator Awards

Congratulations to our inaugural Emerging Leader Investigator Award winners who were announced at the 2021 ACTA ASM. These awards are a great opportunity to showcase new leaders across the sector,…

ACTA welcomes inquiry findings into the approval processes for new drugs and novel medical technologies in Australia

…continuing discussions with the Department of Health about the inquiry recommendations and opportunities for further involvement, on behalf of our Members. View the Inquiry report: https://www.aph.gov.au/Parliamentary_Business/Committees/House/Health_Aged_Care_and_Sport/Newdrugs/Report View ACTAs submission: https://clinicaltrialsalliance.org.au/latest-news/parliamentary-inquiry-into-approval-processes-for-new-drugs-and-novel-medical-technologies/…

A farewell message from our CEO

…difficult decision to step down from my position as CEO and will be finishing up at the end 2021. I am leaving the organisation at a time of great opportunity,…

ACTA welcomes new CEO

…provided significant contributions into the inception and development of national capability networks, international collaborations and product development. “As a member-based organisation, we see Stewart’s arrival as an opportunity to connect…

ACTA’s first Industry Roundtable

ACTA recognises the value of industry-led clinical trials and has identified a need to establish greater engagement between key stakeholders across the full spectrum of clinical trial activity. In partnership…